Literature DB >> 27020899

Per-oral endoscopic myotomy, 1000 cases later: pearls, pitfalls, and practical considerations.

Robert Bechara1, Manabu Onimaru2, Haru Ikeda2, Haruhiro Inoue2.   

Abstract

BACKGROUND AND AIMS: Eight years have passed since the introduction of the per-oral endoscopy myotomy (POEM) procedure. POEM was initially received as an investigational procedure, but since the revelation of promising safety and efficacy data, it is becoming the preferred treatment for achalasia. With the recent completion of our 1000th POEM procedure, we share our experience and knowledge through the discussion of clinical pearls, pitfalls, and practical considerations.
METHODS: The various aspects of the procedure and conditions that warrant special attention are discussed from our perspective, with a focus on areas in which there is currently limited evidence.
RESULTS: The key points on patient position, submucosal tunneling, myotomy, closure, intraprocedural bleeding, and advanced sigmoid achalasia are presented.
CONCLUSIONS: The dissemination of this information serves as a foundation for new POEM operators and as a catalyst for more-experienced operators to further refine and advance their POEM skills and stimulate international discourse and collaboration.
Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27020899     DOI: 10.1016/j.gie.2016.03.1469

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  26 in total

Review 1.  Achalasia: current therapeutic options.

Authors:  Zubin Arora; Prashanthi N Thota; Madhusudhan R Sanaka
Journal:  Ther Adv Chronic Dis       Date:  2017-06-23       Impact factor: 5.091

Review 2.  Advances in Management of Esophageal Motility Disorders.

Authors:  Peter J Kahrilas; Albert J Bredenoord; Dustin A Carlson; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-24       Impact factor: 11.382

Review 3.  Updated Systematic Review of Achalasia, with a Focus on POEM Therapy.

Authors:  Mitchell S Cappell; Stavros Nicholas Stavropoulos; David Friedel
Journal:  Dig Dis Sci       Date:  2019-08-27       Impact factor: 3.199

Review 4.  Current status of achalasia management: a review on diagnosis and treatment.

Authors:  Joshua Tuason; Haruhiro Inoue
Journal:  J Gastroenterol       Date:  2017-02-10       Impact factor: 7.527

5.  Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia.

Authors:  Erica D Kane; Vikram Budhraja; David J Desilets; John R Romanelli
Journal:  Surg Endosc       Date:  2018-07-27       Impact factor: 4.584

6.  Gentamicin submucosal lavage during peroral endoscopic myotomy (POEM): a retrospective analysis.

Authors:  Julia Bayer; Zuzana Vackova; Hana Svecova; Petr Stirand; Julius Spicak; Jan Martinek
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

7.  Establishment of a per oral endoscopic myotomy program at a rural tertiary care center.

Authors:  Austin Rogers; Carlos Anciano; Robert Allman; Dante Dali; Aundrea Oliver; Mark Iannettoni; James Speicher
Journal:  Surg Endosc       Date:  2020-07-15       Impact factor: 4.584

Review 8.  Managing Esophageal Dysphagia in the Elderly.

Authors:  Felice Schnoll-Sussman; Philip O Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-09

Review 9.  Clinical Practice Update: The Use of Per-Oral Endoscopic Myotomy in Achalasia: Expert Review and Best Practice Advice From the AGA Institute.

Authors:  Peter J Kahrilas; David Katzka; Joel E Richter
Journal:  Gastroenterology       Date:  2017-10-06       Impact factor: 22.682

10.  Comparison of outcomes of laparoscopic Heller myotomy versus per-oral endoscopic myotomy for management of achalasia.

Authors:  Steven G Leeds; J S Burdick; Gerald O Ogola; Estrellita Ontiveros
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.